ND-11176

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameND-11176
Drug Alias NameND-11176
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCystic FibrosisMycobacterium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHsiri Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHsiri Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCystic FibrosisMycobacterium Infections

Other Information

ATC CodeN/A
Related LinksN/A